|
|
???tair.name??? >
???browser.page.title.author???
|
"kim dong wan"???jsp.browse.items-by-author.description???
Showing items 1-8 of 8 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺大學術典藏 |
2021-11-29T06:37:51Z |
An International Real-World Analysis of the Efficacy and Safety of Lorlatinib Through Early or Expanded Access Programs in Patients With Tyrosine Kinase Inhibitor-Refractory ALK-Positive or ROS1-Positive NSCLC
|
Zhu, Viola W; YEN-TING LIN; Kim, Dong-Wan; Loong, Herbert H; Nagasaka, Misako; To, Hao; Ang, Yvonne Li-En; Ock, Chan-Young; Tchekmedyian, Nishan; Ou, Sai-Hong Ignatius; Syn, Nicholas L; Reungwetwattana, Thanyanan; Lin, Chia-Chi; Soo, Ross A |
| 臺大學術典藏 |
2020-07-07T08:21:02Z |
Osimertinib in Patients With Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer and Leptomeningeal Metastases: The BLOOM Study
|
Kim, Tae Min; Goldman, Jonathan W.; Natale, Ronald B.; Brown, Andrew P.; Collins, Barbara; Chmielecki, Juliann; Vishwanathan, Karthick; Mendoza-Naranjo, Ariadna; Ahn, Myung-Ju; Stathes Paganis; Lee, Dae H.; Ahn, Jin-Seok; Yang, James C.H.; Kim, Sang-We; Kim, Dong-Wan; Lee, Jong-Seok; Cho, Byoung Chul; Yang, James C.H.;Kim, Sang-We;Kim, Dong-Wan;Lee, Jong-Seok;Cho, Byoung Chul;Ahn, Jin-Seok;Lee, Dae H.;Kim, Tae Min;Goldman, Jonathan W.;Natale, Ronald B.;Brown, Andrew P.;Collins, Barbara;Chmielecki, Juliann;Vishwanathan, Karthick;Mendoza-Naranjo, Ariadna;Ahn, Myung-Ju |
| 臺大學術典藏 |
2020-04-28 |
An international real-world analysis of efficacy and safety of lorlatinib via early or expanded access programs in patients with TKI-refractory ALK+ or ROS1+ NSCLC
|
Soo, Ross A; Chia-Chi Lin; Soo, Ross A;Chia-Chi Lin;Reungwetwattana, Thanyanan;Syn, Nicholas L;Ignatius Ou, Sai-Hong;Tchekmedyian, Nishan;Ock, Chan-Young;Ang, Yvonne L E;To, Hao;Nagasaka, Misako;Loong, Herbert H;Kim, Dong-Wan;YEN-TING LIN;Zhu, Viola W; Zhu, Viola W; YEN-TING LIN; Kim, Dong-Wan; Loong, Herbert H; Nagasaka, Misako; To, Hao; Ang, Yvonne L E; Ock, Chan-Young; Tchekmedyian, Nishan; Ignatius Ou, Sai-Hong; Syn, Nicholas L; Reungwetwattana, Thanyanan |
| 國立臺灣大學 |
2015 |
First-in-human phase I study of EGF816, a third generation, mutant-selective EGFR tyrosine kinase inhibitor, in advanced non-small cell lung cancer (NSCLC) harboring T790M.
|
Tan, Daniel Shao-Weng; Seto, Takashi; Leighl, Natasha B.; Riely, Gregory J.; Sequist, Lecia V.; Felip, Enriqueta; Wolf, Juergen; Yang, James Chih-Hsin; Matushansky, Igor; Yu, Xiaolu; Schmitz, Shu-Fang Hsu; Cui, Xiaoming; Kim, Dong-Wan; 楊志新 |
| 國立臺灣大學 |
2015 |
AZD3759, an EGFR inhibitor with blood brain barrier (BBB) penetration for the treatment of non-small cell lung cancer (NSCLC) with brain metastasis (BM): Preclinical evidence and clinical cases.
|
Kim, Dong-Wan; Yang, James Chih-Hsin; Chen, Kan; Cheng, Ziqiang; Yin, Lucy; Martin, Paul David; Yang, Zhenfan; Jiang, Haiyi; Ahn, Myung-Ju; 楊志新 |
| 國立臺灣大學 |
2015 |
AZD9291 in EGFR Inhibitor-Resistant Non-Small-Cell Lung Cancer
|
Jaenne, Pasi A.; Yang, James Chih-Hsin; Kim, Dong-Wan; Planchard, David; Ohe, Yuichiro; Ramalingam, Suresh S.; Ahn, Myung-Ju; Kim, Sang-We; Su, Wu-Chou; Horn, Leora; Haggstrom, Daniel; Felip, Enriqueta; Kim, Joo-Hang; Frewer, Paul; Cantarini, Mireille; Brown, Kathryn H.; Dickinson, Paul A.; Ghiorghiu, Serban; Ranson, Malcolm; 楊志新 |
| 國立臺灣大學 |
2015 |
AZD9291, a mutant-selective EGFR inhibitor, as first-line treatment for EGFR mutation-positive advanced non-small cell lung cancer (NSCLC): Results from a phase 1 expansion cohort.
|
Ramalingam, Suresh S.; Yang, James Chih-Hsin; Lee, Chee Khoon; Kurata, Takayasu; Kim, Dong-Wan; John, Thomas; Nogami, Naoyuki; Ohe, Yuichiro; Rukazenkov, Yuri; Frewer, Paul; Cantarini, Mireille; Ghiorghiu, Serban; Janne, Pasi A.; 楊志新 |
| 國立臺灣大學 |
2015 |
Antitumor Activity of Tepotinib plus Gefitinib in Asian Patients with Met plus EGFRm plus NSCLC
|
Kim, Dong-Wan; Soo, Ross; Yang, James Chih-Hsin; Park, Keunchil; Stammberger, Uz; Xiong, Huiiling; Ihling, Christian; Wu, Yi-Long; 楊志新 |
Showing items 1-8 of 8 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
